[
  {
    "ts": null,
    "headline": "How IDEXX’s Diagnostics-Focused CEO Transition At IDEXX Laboratories (IDXX) Has Changed Its Investment Story",
    "summary": "On January 13, 2026, IDEXX Laboratories announced that Michael (Mike) Erickson, PhD, will become President and CEO on May 12, 2026, as current President and CEO Jonathan (Jay) Mazelsky moves to Executive Chair before retiring after the May 2027 shareholder meeting. Erickson’s elevation from leading IDEXX’s Global Point of Care Diagnostics and Telemedicine businesses to the top role signals continuity in focusing on advanced diagnostic solutions and healthcare technology innovation. We’ll now...",
    "url": "https://finnhub.io/api/news?id=e27f25f4adbdcb604c56ad23450858174e17b614518f72360b5ff40728be2fbe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768339117,
      "headline": "How IDEXX’s Diagnostics-Focused CEO Transition At IDEXX Laboratories (IDXX) Has Changed Its Investment Story",
      "id": 138094516,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "On January 13, 2026, IDEXX Laboratories announced that Michael (Mike) Erickson, PhD, will become President and CEO on May 12, 2026, as current President and CEO Jonathan (Jay) Mazelsky moves to Executive Chair before retiring after the May 2027 shareholder meeting. Erickson’s elevation from leading IDEXX’s Global Point of Care Diagnostics and Telemedicine businesses to the top role signals continuity in focusing on advanced diagnostic solutions and healthcare technology innovation. We’ll now...",
      "url": "https://finnhub.io/api/news?id=e27f25f4adbdcb604c56ad23450858174e17b614518f72360b5ff40728be2fbe"
    }
  },
  {
    "ts": null,
    "headline": "Dow Jones Retail Giant Amazon Stock Eyes Latest Buy Point",
    "summary": "Dow Jones retail giant Amazon is approaching a fresh buy point, as the stock market holds near record highs.",
    "url": "https://finnhub.io/api/news?id=3677986e67fa36743fff463850a58bdedb559ef4c93c13bbdeaf73b53fa1d579",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768324017,
      "headline": "Dow Jones Retail Giant Amazon Stock Eyes Latest Buy Point",
      "id": 138086514,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "Dow Jones retail giant Amazon is approaching a fresh buy point, as the stock market holds near record highs.",
      "url": "https://finnhub.io/api/news?id=3677986e67fa36743fff463850a58bdedb559ef4c93c13bbdeaf73b53fa1d579"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Announces CEO Succession",
    "summary": "WESTBROOK, Maine, January 13, 2026--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the promotion of Michael (Mike) Erickson, PhD, to President and Chief Executive Officer, effective May 12, 2026, at which time Jonathan (Jay) Mazelsky, President and CEO, will transition to the role of Executive Chair of IDEXX’s Board of Directors (the \"Board\"). Mr. Mazelsky has announced his intention to retire from the Company immediately following the Comp",
    "url": "https://finnhub.io/api/news?id=64c1c8c47b2529fbd5c221180294c494bfb172ea152eb6cccc2b0c0ad1234e28",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768311000,
      "headline": "IDEXX Announces CEO Succession",
      "id": 138083605,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "WESTBROOK, Maine, January 13, 2026--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the promotion of Michael (Mike) Erickson, PhD, to President and Chief Executive Officer, effective May 12, 2026, at which time Jonathan (Jay) Mazelsky, President and CEO, will transition to the role of Executive Chair of IDEXX’s Board of Directors (the \"Board\"). Mr. Mazelsky has announced his intention to retire from the Company immediately following the Comp",
      "url": "https://finnhub.io/api/news?id=64c1c8c47b2529fbd5c221180294c494bfb172ea152eb6cccc2b0c0ad1234e28"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Laboratories (IDXX): From a Detractor to a Revivor",
    "summary": "Fundsmith, an investment management firm based in London, has released its annual 2025 investor letter for its “Fundsmith Equity Fund.” A copy of the letter can be downloaded here. The fund focuses on investing in equities globally. The T Class Accumulation shares where the firm invested returned 0.8% in 2025, compared to 12.8% for the […]",
    "url": "https://finnhub.io/api/news?id=13c0eaf0e3c4a45dbdde778756a7ad14a6c1e790bd5be917f37d58199a2523b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768307982,
      "headline": "IDEXX Laboratories (IDXX): From a Detractor to a Revivor",
      "id": 138083606,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "Fundsmith, an investment management firm based in London, has released its annual 2025 investor letter for its “Fundsmith Equity Fund.” A copy of the letter can be downloaded here. The fund focuses on investing in equities globally. The T Class Accumulation shares where the firm invested returned 0.8% in 2025, compared to 12.8% for the […]",
      "url": "https://finnhub.io/api/news?id=13c0eaf0e3c4a45dbdde778756a7ad14a6c1e790bd5be917f37d58199a2523b5"
    }
  },
  {
    "ts": null,
    "headline": "RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock?",
    "summary": "RxSight (RXST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",
    "url": "https://finnhub.io/api/news?id=d52b5dced744737319d8d8bd1ce12889f97905648b9eda50fca37ffb7108af9f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768302960,
      "headline": "RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock?",
      "id": 138083607,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "RxSight (RXST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",
      "url": "https://finnhub.io/api/news?id=d52b5dced744737319d8d8bd1ce12889f97905648b9eda50fca37ffb7108af9f"
    }
  }
]